CSF1 and neoplasm: Since CSF-1 is needed to polarize the TAMs into the immunosuppressive M2 phenotype at the first stage of their generation [37], the blockade of CSF-1 could decrease the TAMs at the tumor sites, leading to induction of immunoreactive effector T cells at the tumor site [22].